Agilent Names Alacris Theranostics as Certified Provider of Target Enrichment Services
News Jan 17, 2015
Agilent Technologies Inc. has announced that it has named Alacris Theranostics, a Berlin-based company active in the area of next-generation sequencing (NGS)-driven personalized medicine, as an Agilent Certified Service Provider for target enrichment.
Agilent certifies select laboratories that leverage the company's market-leading technologies to provide analysis services of the highest quality. Hands-on training from application scientists on Agilent's proven workflow solutions ensures that customers receive consistent data quality, reproducibility and reliability.
"We are honored to have Alacris Theranostics as part of the Agilent CSP program," said Alessandro Borsatti, senior director of marketing for Agilent's Diagnostics and Genomics Group. "Alacris is known for providing innovative approaches to cancer research and has used Agilent's NGS target enrichment solutions for several years. We look forward to supporting them as they expand their work."
"Becoming an Agilent CSP for targeted enrichment services confirms the high standards adopted by Alacris," said Dr. Bodo M.H. Lange, chief executive at Alacris. "Certification will help to expand our growing reputation and assure our customers and collaborators in the sequencing and personalized medicine sector that we will deliver high-quality results."
Big Data Study Targets Genomic Dark Matter from Ocean Floor to Gut FloraNews
An international team led by computational biologist Fran Supek at IRB Barcelona develop a machine learning method to predict unknown gene functions of microbes.The system examines and compares ‘big data’ available on the metagenomes of human and environmental microbiomes.READ MORE
Bioethics Council Rules Heritable Genome Editing "Ethically Acceptable" In Certain CircumstancesNews
A leading UK bioethics advisory body has weighed in on the debate around human genetic modification, concluding that heritable genome editing – modifying the DNA of an egg, sperm or embryo with changes that will be passed on to future generations – could be ‘morally permissible’ in humans, provided key ethical tests are met.
Hay Fever Risk Genes Overlap with Autoimmune DiseaseNews
In a large international study involving almost 900,000 participants, researchers from the University of Copenhagen and COPSAC have found new risk genes for hay fever. It is the largest genetic study so far on this type of allergy, which affects millions of people around the world.READ MORE